Selective downregulation of Th1 response by Linomide reduces autoimmunity but increases susceptibility to viral infection in BALB/c and SJL mice

被引:12
作者
Eralinna, JP
Roytta, M
Hukkanen, V
Zinhu, D
Salmi, AA
Salonen, R
机构
[1] Univ Turku, Dept Virol, FIN-20520 Turku, Finland
[2] Univ Turku, Dept Pathol, FIN-20520 Turku, Finland
[3] Univ Turku, Turku Immunol Ctr, Turku, Finland
基金
英国医学研究理事会;
关键词
experimental allergic encephalomyelitis; EAE; treatment; cytokines; virus infection; SFV-A7;
D O I
10.1016/S0165-5728(98)00115-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Susceptibility to autoimmunity has been associated with polarization of Th1/Th2 balance in immune system towards the Th1-type of reactivity. We report here that orally administered quinoline-3-carboxamide (Linomide(R)) selectively downregulates Th1 response in BALB/c and SJL mice, leading to reduction of autoimmunity in the BALB/c and SJL models of experimental allergic encephalomyelitis (EAE). This was shown by prevention of EAE in Th1 responding SJL mice and partial downregulation of EAE in Th2-prone BALB/c mice. In a BALB/c model of EAE, in which infection with Semliki Forest A7 virus (SFV-A7) is used for enhancement of autoimmunity, clinical signs of EAE were reduced while mortality due to viral infection in the CNS was enhanced. Selective downregulation of the Th1 response by Linomide also rendered initially resistant SJL mice susceptible to SFV-A7 CNS infection. This was shown by immunohistochemical detection of extensive deposits of viral antigen in numerous perivascular foci within the CNS and abolished virus antigen-specific lymphocyte reactivity in Linomide-treated Sn mice. In addition, analysis of spleen cell cytokine mRNA production profile revealed decreased number of IFN-gamma producing cells in both SJL and BALB/c mice, reduced number of IL-12p40 producing cells in SJL and increased number of IL-12p40 producing cells in BALB/c mice along with slightly increased IL-4 production in both strains of mice. These results indicate that oral treatment with Linomide induces selective downregulation of Th1 reactivity causing reduction of autoimmunity and increased susceptibility to SFV-A7 CNS infection. Selective downregulation of Thl response is a desired effect in the treatment of autoimmune diseases but our results suggest that the benefits have to be balanced against the possible loss in immunoprotection against pathogens. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:165 / 176
页数:12
相关论文
共 39 条
[1]   Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis [J].
Amor, S ;
Scallan, MF ;
Morris, MM ;
Dyson, H ;
Fazakerley, JK .
JOURNAL OF GENERAL VIROLOGY, 1996, 77 :281-291
[2]   Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosis [J].
Andersen, O ;
Lycke, J ;
Tollesson, PO ;
Svenningsson, A ;
Runmarker, B ;
Linde, AS ;
Astrom, M ;
Gjorstrup, P ;
Ekholm, S .
NEUROLOGY, 1996, 47 (04) :895-900
[3]   Linomide, an immunomodulator that inhibits T(h)1 cytokine gene expression [J].
Arad, G ;
Katzenellenbogen, M ;
Levy, R ;
Slavin, S ;
Kaempfer, R .
INTERNATIONAL IMMUNOLOGY, 1996, 8 (10) :1603-1607
[4]   Linomide-induced suppression of experimental autoimmune neuritis is associated with down-regulated macrophage functions [J].
Bai, XF ;
Shi, FD ;
Zhu, J ;
Xiao, BG ;
Hedlund, G ;
Link, H .
JOURNAL OF NEUROIMMUNOLOGY, 1997, 76 (1-2) :177-184
[5]   STIMULATION OF NK CELL, T-CELL, AND MONOCYTE FUNCTIONS BY THE NOVEL IMMUNOMODULATOR LINOMIDE AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION - A PILOT-STUDY IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA [J].
BENGTSSON, M ;
SIMONSSON, B ;
CARLSSON, K ;
NILSSON, B ;
SMEDMYR, B ;
TERMANDER, B ;
OBERG, G ;
TOTTERMAN, TH .
TRANSPLANTATION, 1992, 53 (04) :882-888
[6]  
BILLIAU A, 1988, J IMMUNOL, V140, P1506
[7]   A SOLID-PHASE ENZYME-LINKED IMMUNOSPOT (ELISPOT) ASSAY FOR ENUMERATION OF SPECIFIC ANTIBODY-SECRETING CELLS [J].
CZERKINSKY, CC ;
NILSSON, LA ;
NYGREN, H ;
OUCHTERLONY, O ;
TARKOWSKI, A .
JOURNAL OF IMMUNOLOGICAL METHODS, 1983, 65 (1-2) :109-121
[8]   EFFECT OF ANTI-INTERFERON-GAMMA AND ANTI-INTERLEUKIN-2 MONOCLONAL-ANTIBODY TREATMENT ON THE DEVELOPMENT OF ACTIVELY AND PASSIVELY INDUCED EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN THE SJL/J MOUSE [J].
DUONG, TT ;
STLOUIS, J ;
GILBERT, JJ ;
FINKELMAN, FD ;
STREJAN, GH .
JOURNAL OF NEUROIMMUNOLOGY, 1992, 36 (2-3) :105-115
[9]   Blood-brain barrier breakdown and increased intercellular adhesion molecule (ICAM-1/CD54) expression after Semliki Forest (A7) virus infection facilitates the development of experimental allergic encephalomyelitis [J].
Eralinna, JP ;
SoiluHanninen, M ;
Roytta, M ;
Hukkanen, V ;
Salmi, AA ;
Salonen, R .
JOURNAL OF NEUROIMMUNOLOGY, 1996, 66 (1-2) :103-114
[10]   FACILITATION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY IRRADIATION AND VIRUS-INFECTION - ROLE OF INFLAMMATORY CELLS [J].
ERALINNA, JP ;
SOILUHANNINEN, M ;
ROYTTA, M ;
ILONEN, J ;
MAKELA, M ;
SALMI, A ;
SALONEN, R .
JOURNAL OF NEUROIMMUNOLOGY, 1994, 55 (01) :81-90